Perez-Castañeda MR

Language: English
References: 11
Page: 106-107
PDF size: 59.43 Kb.

Text Extraction

Last October 20-22nd, 2010 it was celebrated the 2010 edition to the congress Biotechnology Havana (BH2010) organized every year by the Center for Genetic Engineering and Biotechnology. The BH2010 Conference focused on the Integral Care of Diabetic Foot Ulcer Patients with the Use of Heberprot-P. The Congress was attended by 366 delegates from 36 countries. It was organized in two symposia with 6 plenary lectures, 25 lectures and 120 posters. Symposia were focused on the Molecular biology of growth factors, and the Integral Care to Diabetic Foot Ulcers, Current Status, respectively. The BH2010 lectures were given by representatives of 11 countries from the Americas, Europe and Asia, covering the following issues: Epidermal growth factor, its molecular biology and other molecules used to promote wound healing, clinical experience on using Heberprot-P, therapeutic experience in diabetic foot ulcers and organizational strategies in organizing and extending health services to attend DFU patients. It was evident that Heberprot-P emerged as the unique therapy available to successfully cicatrize Wagner 3-4 DFUs in diabetic patients.

REFERENCES

1. MedMarket Diligence (Internet). California: MedMarket Diligence, LLC; c2001-2011 (cited 2011 May 10). Available from: http://mediligence.com.

2. Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care. 1999; 22: 1354-60.

3. Berlanga J. Heberprot-P: experimental background and pharmacological bases. Biotecnol Apl. 2010; 27: 88-94.

4. Fernandez-Montequin J, Mena G, Santiesteban Ll. Treatment and recovery of Wagner 5 diabetic foot with Heberprot-P. Biotecnol Apl. 2010; 27: 113-5.

5. Gil M, López-Mola E, Alvarez H, Hernández A, Pérez C, Year I, et al. Experiences in the nationwide program for the integral care of the patient with diabetic foot ulcer using Heberprot-P. Biotecnol Apl. 2010; 27: 147-50.

6. Biotechnology Havana 2010. Abstract Book; 2010 Oct 20-22; Havana, Cuba. Havana: Editorial Elfos Scientiae; 2010.

7. Practical Application of Heberprot-P in Diabetic Foot Ulcer Patients. Pre-Congress Course - Workshop (Internet). Havana: Center for Genetic Engineering and Biotechnology; c2010 (updated 2010 Oct 17; cited 2011 May 10). Biotechnology Havana 2010; about 4 screens. Available from: http://bh2010.cigb.edu.cu/index.php?option=com_content&view=article&id=38&Itemid=30&lang=en.

8. Lopez-Mola E. El Heberprot-P. Una idea convertida en producto (dissertation). Biotechnology Havana 2010. 2010 Oct 22; Havana ( Cuba). (cited 2011 May 10). Available from: http://bh2010.cigb.edu.cu/Conferencias/ErnestoL.pdf.

9. Martinez F. Eficacia de piel cultivada de keratinocitos neonatales en la aceleración de la cicatrización de las ulceras neuropáticas del pie diabético. (dissertation). Biotechnology Havana 2010. 2010 Oct 22; Havana ( Cuba).

10. Cuba wins awards for diabetic foot treatment (Internet). United Kingdom: Schofield Publishing Ltd; c2011 (cited 2011 May 10). Wounds International; (1 screen). Available from: http://www.woundsinternational.com/article.php?contentid=131&articleid=9812&page=1.

11. HEBERPROT-P HAVANA 2012. II International Congress addressed to the Integral Care of Diabetic Foot Ulcer Patient with the use of Heberprot-P, and II International Workshop about the Practical Application of Heberprot-P in Diabetic Foot Ulcer Patients (Internet). Havana: Center for Genetic Engineering and Biotechnology; c2011-2012 (updated 2011 May 17, cited 2011 May 21). Available from: http://Heberprot-PHavana2012.cigb.edu.cu.